Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Altria Group, Inc.    MO

ALTRIA GROUP, INC.

(MO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Marlboro maker Altria takes $2.6 billion hit as Juul valuation crumbles

10/30/2020 | 02:37pm EST
FILE PHOTO: Juul brand vape cartridges are pictured for sale at a shop in Atlanta

(Reuters) - Altria Group Inc on Friday took a third-quarter hit of $2.6 billion to its investment in Juul Labs Inc, further diminishing the value of its initial $12.8 billion stake in the e-cigarette maker that is facing increased regulatory scrutiny.

Its stake in Juul is now worth $1.6 billion, the company said, implying that the value of the vaping products maker was a fraction of the $38 billion it was worth when the cigarette company picked up a 35% stake in December 2018.

Altria has so far taken $11.2 billion in write-downs as Juul's valuation nosedived when regulators stepped up pressure following a rise in teenage vaping and a ban on the sale of popular flavors.

Juul, which recently decided to quit certain markets, had cut its valuation to about $10 billion from $12 billion at the end of last year, Reuters reported on Thursday, citing an internal memo.

However, Altria's valuation of its stake implied it values Juul at about $4.6 billion, less than half of Juul's own valuation, a Reuters calculation showed.

Altria said on Friday it considered Juul's international prospects and current U.S. e-vapor category dynamics in its valuation analysis.

"The e-vapor category will continue to undergo a transition period over the next few years as FDA makes market determinations on the thousands of PMTAs (Premarket Tobacco Product Application)," Chief Executive Officer Billy Gifford told analysts.

The U.S. Food and Drug Administration has moved Juul's PMTA into scientific review, Altria said. The health regulator had said https://bit.ly/34EUBa6 in September it may notify e-cigarette makers if their products have deficiencies or else take a positive or negative decision.

Shares of Altria, down about 27% so far this year, fell about 2%. The company reported better-than-expected quarterly results and narrowed its 2020 adjusted diluted profit per share forecast range.

(Reporting by Praveen Paramasivam in Bengaluru; Editing by Arun Koyyur)


© Reuters 2020
All news about ALTRIA GROUP, INC.
07:05aALTRIA GROUP, INC. : Regulation FD Disclosure, Financial Statements and Exhibits..
AQ
07:02aALTRIA : Participates in the Morgan Stanley Global Consumer and Retail Conferenc..
BU
11/19Big Tobacco gets a pandemic pick-me-up
RE
11/16ALTRIA : Announces Conversion of Its Non-Voting Shares in JUUL; Does Not Intend ..
AQ
11/14ELON MUSK : Elon Musk Says He Tested Positive for Covid-19 -- 7th Update
DJ
11/14ELON MUSK : Elon Musk Says He Tested Positive for Covid-19 -- 6th Update
DJ
11/13ELON MUSK : Tesla CEO Says He Tests Both Positive and Negative -- 4th Update
DJ
11/13ELON MUSK'S COVID-19 TESTS : Tesla CEO Says He Tests Both Positive and Negative ..
DJ
11/13ELON MUSK'S COVID-19 TESTS : Tesla CEO Says He Tests Both Positive and Negative ..
DJ
11/13ELON MUSK'S COVID-19 TESTS : Tesla CEO Says He Tests Both Positive and Negative ..
DJ
More news
Financials (USD)
Sales 2020 20 727 M - -
Net income 2020 4 505 M - -
Net Debt 2020 25 150 M - -
P/E ratio 2020 16,8x
Yield 2020 8,42%
Capitalization 75 247 M 75 247 M -
EV / Sales 2020 4,84x
EV / Sales 2021 4,74x
Nbr of Employees 7 300
Free-Float 66,2%
Chart ALTRIA GROUP, INC.
Duration : Period :
Altria Group, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALTRIA GROUP, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 48,28 $
Last Close Price 40,49 $
Spread / Highest target 67,9%
Spread / Average Target 19,2%
Spread / Lowest Target -8,62%
EPS Revisions
Managers
NameTitle
William F. Gifford Vice Chairman & Chief Executive Officer
Thomas F. Farrell Independent Chairman
Jody L. Begley Chief Operating Officer & Executive Vice President
Salvatore Mancuso Chief Financial Officer & Executive Vice President
George Muñoz Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ALTRIA GROUP, INC.-18.87%75 247
JAPAN TOBACCO INC.-12.35%36 270
ITC LIMITED-18.22%32 541
PT HANJAYA MANDALA SAMPOERNA TBK-21.19%12 835
KT&G CORPORATION-10.23%9 341
PT GUDANG GARAM TBK-15.99%5 833